Matches in SemOpenAlex for { <https://semopenalex.org/work/W2425926083> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2425926083 endingPage "9" @default.
- W2425926083 startingPage "2373" @default.
- W2425926083 abstract "The pharmacokinetics of IP CBDCA was compared with IV CBDCA and a dose-up study of IV CPM was performed in combination with 400 mg/m2 IP CBDCA for advanced ovarian cancer patients. The maximum concentration of free platinum (F-Pt) in serum following IP CBDCA administration was approximately 1/3 that of F-Pt following IV CBDCA. F-Pt in serum remained more than 90% of total platinum following IP CBDCA until 12 hours after administration. The t1/2 of F-Pt in serum after IP CBDCA administration was two times longer when compared with t1/2 following IV CBDCA, showing the slow peritoneal clearance of CBDCA. The area under curve (AUC) following IP CBDCA was approximately 67% of AUC following IV CBDCA. Cumulative urinary secretion (CUS) of platinum following IP CBDCA was 37% of CUS after IV CBDCA. The maximum tolerable dose of IV CPM in combination with 400 mg/m2 IP CBDCA was 550-600 mg/m2. The dose limiting factor of this combination therapy was leukocytopenia. Thrombocytopenia was mild in this study. Combination of 400 mg/m2 IP CBDCA and 550-600 mg/m2 seemed to be a tolerable and repeatable therapy for most patients with advanced ovarian carcinoma. Since thrombocytopenia was mild and the pharmacokinetics showed the smaller AUC of free platinum in serum following IP CBDCA, a dose-up study for IP CBDCA should be considered." @default.
- W2425926083 created "2016-06-24" @default.
- W2425926083 creator A5005110163 @default.
- W2425926083 creator A5005740666 @default.
- W2425926083 creator A5025271372 @default.
- W2425926083 creator A5028272811 @default.
- W2425926083 creator A5028579678 @default.
- W2425926083 creator A5072614361 @default.
- W2425926083 creator A5086729350 @default.
- W2425926083 date "1992-12-01" @default.
- W2425926083 modified "2023-09-23" @default.
- W2425926083 title "[The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients]." @default.
- W2425926083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1463344" @default.
- W2425926083 hasPublicationYear "1992" @default.
- W2425926083 type Work @default.
- W2425926083 sameAs 2425926083 @default.
- W2425926083 citedByCount "0" @default.
- W2425926083 crossrefType "journal-article" @default.
- W2425926083 hasAuthorship W2425926083A5005110163 @default.
- W2425926083 hasAuthorship W2425926083A5005740666 @default.
- W2425926083 hasAuthorship W2425926083A5025271372 @default.
- W2425926083 hasAuthorship W2425926083A5028272811 @default.
- W2425926083 hasAuthorship W2425926083A5028579678 @default.
- W2425926083 hasAuthorship W2425926083A5072614361 @default.
- W2425926083 hasAuthorship W2425926083A5086729350 @default.
- W2425926083 hasConcept C112705442 @default.
- W2425926083 hasConcept C121608353 @default.
- W2425926083 hasConcept C126322002 @default.
- W2425926083 hasConcept C2776694085 @default.
- W2425926083 hasConcept C2778239845 @default.
- W2425926083 hasConcept C2780427987 @default.
- W2425926083 hasConcept C2781451048 @default.
- W2425926083 hasConcept C71924100 @default.
- W2425926083 hasConcept C76318530 @default.
- W2425926083 hasConcept C98274493 @default.
- W2425926083 hasConceptScore W2425926083C112705442 @default.
- W2425926083 hasConceptScore W2425926083C121608353 @default.
- W2425926083 hasConceptScore W2425926083C126322002 @default.
- W2425926083 hasConceptScore W2425926083C2776694085 @default.
- W2425926083 hasConceptScore W2425926083C2778239845 @default.
- W2425926083 hasConceptScore W2425926083C2780427987 @default.
- W2425926083 hasConceptScore W2425926083C2781451048 @default.
- W2425926083 hasConceptScore W2425926083C71924100 @default.
- W2425926083 hasConceptScore W2425926083C76318530 @default.
- W2425926083 hasConceptScore W2425926083C98274493 @default.
- W2425926083 hasIssue "14" @default.
- W2425926083 hasLocation W24259260831 @default.
- W2425926083 hasOpenAccess W2425926083 @default.
- W2425926083 hasPrimaryLocation W24259260831 @default.
- W2425926083 hasRelatedWork W1489103099 @default.
- W2425926083 hasRelatedWork W1848577014 @default.
- W2425926083 hasRelatedWork W1898544704 @default.
- W2425926083 hasRelatedWork W1976375274 @default.
- W2425926083 hasRelatedWork W2034009362 @default.
- W2425926083 hasRelatedWork W2038136053 @default.
- W2425926083 hasRelatedWork W2131322929 @default.
- W2425926083 hasRelatedWork W4571420 @default.
- W2425926083 hasRelatedWork W2181705857 @default.
- W2425926083 hasRelatedWork W2185009457 @default.
- W2425926083 hasVolume "19" @default.
- W2425926083 isParatext "false" @default.
- W2425926083 isRetracted "false" @default.
- W2425926083 magId "2425926083" @default.
- W2425926083 workType "article" @default.